Indian drug maker Dr Reddy's Laboratories Ltd (REDY.BO: Quote, Profile, Research, Stock Buzz) has received approval from the U.S. Food and Drug Administration to sell its anti-convulsant drug primidone, the regulator's website showed.

Dr Reddy's is allowed to sell the drug in the United States in tablet forms of 50 milligram and 250 milligram strengths, the website showed.